Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.21.3 (
deoxyribonuclease
)
1,528
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The activity of most
deoxyribonuclease
enzymes can be monitored by measuring the change in absorbance at 260 nm which accompanies the breakdown of the double-stranded structure of native DNA. An automated method for determining
deoxyribonuclease
activity, based on such an absorbance change, which can overcome problems of inhibition arising from the presence of inorganic cations, is described. Variations in inorganic cation concentration is a particular problem when measuring the activity of chromatographic fractions eluted via a salt gradient. A comparison is made between the automated and a manual method for the assay of
deoxyribonuclease
active constituents, of the medicament 'Varidase', eluted from a Cellex-D (Bio-
Rad
Laboratories Ltd) anionic exchange resin using a 0.05-1.0 M sodium chloride gradient.
...
PMID:An automated method for the determination of deoxyribonuclease activity as exemplified by fractionation of the components of the medicament Varidase. 1892 62